NCT05203835View on ClinicalTrials.gov

Trial of Acebilustat for the Treatment of Upper Arm Lymphedema

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 27, 2022

Primary Completion Date

October 21, 2025

Study Completion Date

March 31, 2026

Conditions
Lymphedema of Upper Arm
Interventions
DRUG

Acebilustat

By mouth, once a day, 100 mg capsule

DRUG

Placebo

Placebo to match acebilustat by mouth, once a day

Trial Locations (1)

94305

Stanford University, Palo Alto

All Listed Sponsors
collaborator

Celltaxis LLC

UNKNOWN

lead

Stanford University

OTHER